Significant weight loss, including weight loss associated with GLP-1 receptor agonist medications, may lead to a reduction in facial fat volume. This can result in a more hollow appearance, loss of facial fullness, increased skin laxity, and a tired or aged facial appearance. These changes are commonly referred to in the media as "Ozempic Face," although they are generally related to rapid weight loss rather than to a specific medication itself.
